Skip to main content
    A

    Anika Therapeutics Inc (ANIK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $14.55
    -4.78 (-24.73%)

    Market Cap: $258.69M

    Last updated: Nov 06, 2026 at 4:11 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +42.15%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.85
    Range$0.85 - $0.85
    1 analysts
    Revenue Consensus
    $35M
    Range$34M - $36M
    2 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.85$0.85 - $0.85--1--
    Sep 26
    Reported Nov 6
    		$0.29$0.02$0.02 - $0.02+1350.00%Beat1
    1
    0
    30d
    		+270.6%
    Jun 26
    Reported Jul 29
    		$0.30$-0.19$-0.19 - $-0.19+257.89%Beat1
    0
    1
    30d
    		+330.8%
    Mar 26
    Reported Apr 29
    		$0.27$-0.16$-0.16 - $-0.16+268.75%Beat1
    0
    1
    30d
    		+550.0%
    Dec 25
    Reported Feb 26
    		$0.13$-0.19$-0.19 - $-0.19+168.42%Beat1
    0
    1
    30d
    		+192.9%
    Sep 25
    Reported Nov 5
    		$-0.17$-0.19$-0.19 - $-0.19+10.53%Beat1
    0
    1
    30d
    		+32.0%
    Jun 25
    Reported Jul 30
    		$-0.13$-0.13$-0.13 - $-0.13+0.00%Beat1
    0
    1
    30d
    		-176.5%
    Mar 25
    Reported May 9
    		$-0.06$0.09$0.09 - $0.09-166.67%Miss1
    0
    1
    30d
    		-166.7%
    Dec 24
    Reported Mar 12
    		$-0.14$-0.11$-0.11 - $-0.11-27.27%Miss1
    1
    1
    30d
    		+96.7%
    Sep 24
    Reported Oct 31
    		$-0.25$0.30$0.22 - $0.37-183.33%Miss2
    No revisions (30d)
    		+44.4%
    Jun 24
    Reported Aug 8
    		$0.17$0.20$0.14 - $0.31-15.00%Miss3
    No revisions (30d)
    		+183.3%
    Mar 24
    Reported May 8
    		$0.09$0.05-+80.00%Beat3
    0
    1
    30d
    		+125.0%
    Dec 23
    Reported Mar 13
    		$-4.30$-0.26$-0.32 - $-0.21-1553.85%Miss3
    No revisions (30d)
    		-1164.7%

    Key Metrics

    Valuation
    P/E Ratio14.70EV/EBITDA48.82x
    Price/FCF84.88xFCF Yield1.18%
    Profitability
    Profit Margin-3.14%Operating Margin11.40%
    ROE-2.19%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.86xQuick Ratio2.72x
    Trading Statistics
    Beta0.20Avg Volume112.92K
    52-Week High$22.8852-Week Low$9.01

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$20.00
    SMA 20$20.29
    SMA 50$20.38
    SMA 200$16.30
    EMA 10$19.25
    EMA 20$19.85
    EMA 50$19.93
    EMA 200$16.96

    MACD

    Line: -0.52Signal: -0.02Hist: -0.50

    ADX

    ADX: 21.3+DI: 9.8-DI: 44.4

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down100.0
    PSAR$21.48

    Bollinger Bands

    Upper Band$23.33
    Lower Band$17.24
    %B Position3004%(Upper)
    Band Width-0.44

    RSI (14-Day)

    Oversold
    23.8

    Momentum Oscillators

    Stoch %K21.9
    Stoch %D22.4
    Williams %R-92.1
    ROC (10d)-32.1%
    Momentum-6.87
    CCI (20d)-473.3
    MFI (14d)69.9

    Volatility Measures

    ATR (14d)$1.30(8.9%)
    StdDev (20d)1.52
    Hist Vol100.0%(High)

    Volume Flow

    VWAP$15.45
    OBV4.8M
    AD Line-303.8K
    CMF (20d)0.025

    Volume Metrics

    Avg Vol (20d)113.5K
    Vol Ratio2.6x(High)
    VWMA (20d)$19.77

    Pivot Points

    R3$21.81
    R2$21.21
    R1$20.27
    Pivot Point$19.67
    S1$18.73
    S2$18.13
    S3$17.19

    Advanced Oscillators

    TSI-15.52
    Ultimate Osc27.8
    KST-5.49

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$30.59M$32.61M$29.61M$30.61M$27.82M$28.22M$26.17M$30.60M$29.56M$30.72M$29.02M$-2,899,000
    Cost of Revenue$11.76M$11.37M$10.62M$11.44M$12.23M$13.86M$11.49M$13.48M$10.15M$10.23M$10.05M$-8,672,000
    Gross Profit$18.84M$21.24M$19.00M$19.18M$15.58M$14.36M$14.68M$17.13M$19.41M$20.49M$18.98M$5.77M
    Operating Expenses$19.55M$18.29M$24.48M$18.53M$18.82M$18.54M$18.96M$17.83M$19.49M$22.30M$21.48M$-18,929,000
    R&D$7.89M$7.34M$6.71M$6.45M$6.95M$6.31M$6.06M$6.51M$5.95M$6.68M$6.41M$-3,342,000
    SG&A$11.65M$10.95M$17.77M$12.08M$11.87M$12.23M$12.91M$11.32M$13.54M$15.62M$15.07M$-15,587,000
    Operating Income$-712,000$2.95M$-5,488,000$646,000$-3,233,000$-4,180,000$-4,284,000$-705,000$-81,000$-1,810,000$-2,505,000$24.70M
    Interest Income$390,000$426,000$667,000$118,000$997,000$214,000$415,000$744,000$406,000$595,000$592,000$577,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-322,000$3.38M$-4,821,000$764,000$-2,236,000$-3,966,000$-3,869,000$39,000$325,000$-1,215,000$-1,913,000$25.28M
    Income Tax Expense$-11,000$71,000$235,000$-1,037,000$939,000$681,000$89,000$2.52M$2.17M$1.33M$43,000$9.05M
    Net Income$-311,000$3.31M$-5,056,000$292,000$-2,329,000$-3,970,000$-4,873,000$-21,865,000$-29,918,000$-88,000$-4,514,000$-63,000,000
    EBITDA$727,000$4.46M$-4,081,000$1.96M$-1,830,000$-2,764,000$-2,692,000$1.11M$2.11M$248,000$-442,000$28.28M
    EBIT$-712,000$2.95M$-5,488,000$646,000$-3,233,000$-4,180,000$-4,284,000$-705,000$-81,000$-1,810,000$-2,505,000$24.70M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ANIK

    News

    Anika Therapeutics Q3 2026 Earnings Call Transcript

    Anika Therapeutics (NASDAQ: ANIK) reported a 10% revenue increase in Q3 2026, driven by growth in both commercial and OEM channels...

    Benzinga•11/6/26•Neutral

    Anika Therapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:ANIK) 2026-11-06

    Anika Therapeutics, Inc. (NASDAQ:ANIK) has published its Q3 2026 earnings call presentation, reporting an EPS of $0.29, beating estimates by $0.12. The company also announced revenue of $30.59M...

    Seeking Alpha•11/6/26•Neutral

    Anika Therapeutics, Inc. (ANIK) Seasonal returns chart

    The article presents a seasonal returns chart for Anika Therapeutics, Inc. (ANIK), showing its average monthly price return from 2016 to 2026. As of October 30, the stock price was $20.95...

    Yahoo Finance Australia•10/31/26•Bearish

    Anika Therapeutics, Inc. (ANIK) Seasonal returns chart

    This article provides a seasonal returns chart for Anika Therapeutics, Inc. (ANIK), displaying the average monthly price return from 2016 to 2026. The stock closed at 19.41 USD, experiencing a 7.35% drop on November 2nd.

    Yahoo Finance UK•10/30/26•Somewhat-Bearish

    Understanding Momentum Shifts in (ANIK)

    This article analyzes Anika Therapeutics Inc. (NASDAQ: ANIK) using AI models to identify momentum shifts. It highlights a near-term neutral sentiment amidst mid and long-term strength...

    Stock Traders Daily•10/30/26•Neutral

    ANIK Valuation and Fair Value

    P/E
    14.7x
    Forward P/E
    21.5x
    EV/EBITDA
    48.8x
    P/FCF
    84.9x
    PEG
    2.1x
    P/B
    1.4x
    See GNG's fair value

    ANIK Profitability: Margins, ROIC and FCF

    Gross margin
    63.4%
    Operating margin
    11.4%
    Net margin
    -3.1%
    ROE
    -2.2%
    FCF margin
    1.9%
    FCF yield
    1.2%

    ANIK Competitors

    CompanyTicker
    ARS Pharmaceuticals, IncSPRY
    QuantumSi IncQSI
    Q32 Bio IncQTTB
    BioAge Labs, IncBIOA
    Rocket Pharmaceuticals IncRCKT
    Spok Holdings IncSPOK
    InfuSystems Holdings IncINFU
    Profound Medical CorpPROF

    Sector: Healthcare

    ANIK Bull Case vs Bear Case

    Bull case

    • ANIK grew quarterly revenue 15.6% year over year.

    Bear case

    • ANIK has a -3.1% net profit margin.

    ANIK Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    232.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.85

    ANIK Earnings Date

    ANIK reports Feb 24, 2027, after the close. The date is estimated.

    ANIK Earnings Call

    The latest ANIK earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    ANIK ETF Holders

    GNG tracks 5 ETFs that hold ANIK. The largest weights:

    1. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    2. iShares Russell 2000 ETF (IWM), <0.01% of the fund
    3. Schwab U.S. Broad Market ETF (SCHB), <0.01% of the fund
    4. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    5. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), <0.01% of the fund
    Open the ETF Stock Exposure tool for ANIK

    See insider activity

    Frequently Asked Questions About ANIK

    When does ANIK report earnings?

    Anika Therapeutics Inc (ANIK) is expected to report earnings on Feb 24, 2027.

    Does ANIK pay dividends?

    Anika Therapeutics Inc (ANIK) does not currently pay a regular dividend.

    What is ANIK's P/E ratio?

    Anika Therapeutics Inc has a price-to-earnings (P/E) ratio of 14.70.

    What is ANIK's market cap?

    Anika Therapeutics Inc (ANIK) has a market capitalization of $258.69M with a current stock price of $14.55.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In